Chang Jing

Statistics

Publications

Citations

151

H-Index

Active since

2014

Affiliations

Scripps Research Institute(Current)

Nanjing Tech University

Peking University

Tsinghua University

National Heart Lung and Blood Institute

Chang Jing is an author at Scripps Research Institute specializing in hydrogel biomaterials, therapeutic monoclonal antibodies, and vitreous substitute biomaterials.

ORCID

Publications per year

2014–2022

Publications

An in situ-forming zwitterionic hydrogel as vitreous substitute

Chang Jing, Yong Tao, Bin Wang et al. · Journal of Materials Chemistry B · 2014 · 59 citations

Natural Sciences, Bioengineering, Biomedical Engineering +17

Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility

Haiyong Peng, Thomas Nerreter, Chang Jing et al. · Journal of Molecular Biology · 2017 · 45 citations · Full text

Pharmacy, Immunology, Pharmaceutical Biotechnology +17

Evaluation of a redox-initiated in situ hydrogel as vitreous substitute

Chang Jing, Yong Tao, Bin Wang et al. · Polymer · 2014 · 22 citations

Natural Sciences, Bioengineering, Biomedical Engineering +11

Siglec-6 on Chronic Lymphocytic Leukemia Cells Is a Target for Post-Allogeneic Hematopoietic Stem Cell Transplantation Antibodies

Chang Jing, Haiyong Peng, Brian C. Shaffer et al. · Cancer Immunology Research · 2018 · 15 citations · Full text

Pharmacy, Immunology, Molecular Biology +17

Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia

Matthew G. Cyr, Maissa Mhibik, Junpeng Qi et al. · Journal for ImmunoTherapy of Cancer · 2022 · 10 citations · Full text

Pharmacy, Immunology, Oncology +17

1–5 of 5